Page last updated: 2024-11-01

nevirapine and Cognitive Decline

nevirapine has been researched along with Cognitive Decline in 2 studies

Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.

Research Excerpts

ExcerptRelevanceReference

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Zulu, SS1
Abboussi, O1
Simola, N1
Mabandla, MV1
Daniels, WMU1
De Benedetto, I1
Trunfio, M1
Guastamacchia, G1
Bonora, S1
Calcagno, A1

Reviews

1 review available for nevirapine and Cognitive Decline

ArticleYear
A review of the potential mechanisms of neuronal toxicity associated with antiretroviral drugs.
    Journal of neurovirology, 2020, Volume: 26, Issue:5

    Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Astrocytes; Atazanavir Sulfate; Ben

2020

Other Studies

1 other study available for nevirapine and Cognitive Decline

ArticleYear
Anti-HIV drugs promote β-amyloid deposition and impair learning and memory in BALB/c mice.
    Acta neuropsychiatrica, 2020, Volume: 32, Issue:5

    Topics: Administration, Oral; AIDS Dementia Complex; Amyloid beta-Peptides; Amyloid beta-Protein Precursor;

2020